Featured Research

from universities, journals, and other organizations

Study Ties Gene To Faster Progression Of Multiple Sclerosis Symptoms

Date:
February 16, 2001
Source:
American Academy Of Neurology
Summary:
Multiple sclerosis patients who were carriers of the APOE, or apolipoprotein E, gene are more likely to experience faster progression of disability from the disease, according to a study reported in Neurology, the scientific journal of the American Academy of Neurology.

Multiple sclerosis patients who were carriers of the APOE, or apolipoprotein E, gene are more likely to experience faster progression of disability from the disease, according to a study reported in Neurology, the scientific journal of the American Academy of Neurology.

Related Articles


MS is a chronic inflammatory disease of the central nervous system characterized by flare-ups followed by remissions. APOE, important in lipid transport, also acts as a factor in nerve growth, and may advance the disease’s disabling symptoms. There are three common varieties of APOE and the APOE 4 allele has been consistently associated with an increased risk of Alzheimer’s disease.

The study of the linkage between the APOE gene and MS progression was one of the largest to date, including 205 MS patients, 41 with the APOE gene, and 164 without. The appearance of the gene in the study subjects was consistent with the frequency it is found in the general population.

Tests to measure disability status were performed every three to six months, beginning with the time of onset of the disease, and at five and 10 years following onset. According to study author Amos D. Korczyn, a neurologist at Tel Aviv University in Israel, there was a trend toward higher disability among the APOE group at five years, but the difference increased significantly at 10 years. “The proportion of patients considered to have progressive forms of MS was significantly higher among APOE carriers,” Korczyn said.

The presence of the APOE gene also coincided with earlier onset of the disease. The average age of onset of the disease was 31.8 years old, while those without the APOE had an average onset age of 35.1.

The American Academy of Neurology, an association of more than 17,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research.

For more information about the American Academy of Neurology, visit its Web site at http://www.aan.com.


Story Source:

The above story is based on materials provided by American Academy Of Neurology. Note: Materials may be edited for content and length.


Cite This Page:

American Academy Of Neurology. "Study Ties Gene To Faster Progression Of Multiple Sclerosis Symptoms." ScienceDaily. ScienceDaily, 16 February 2001. <www.sciencedaily.com/releases/2001/02/010214075159.htm>.
American Academy Of Neurology. (2001, February 16). Study Ties Gene To Faster Progression Of Multiple Sclerosis Symptoms. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2001/02/010214075159.htm
American Academy Of Neurology. "Study Ties Gene To Faster Progression Of Multiple Sclerosis Symptoms." ScienceDaily. www.sciencedaily.com/releases/2001/02/010214075159.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins